These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 8288720
1. In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas. Stefaneanu L, Kovacs K, Horvath E, Lloyd RV, Buchfelder M, Fahlbusch R, Smyth H. J Clin Endocrinol Metab; 1994 Jan; 78(1):83-8. PubMed ID: 8288720 [Abstract] [Full Text] [Related]
2. Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. Zafar M, Ezzat S, Ramyar L, Pan N, Smyth HS, Asa SL. J Clin Endocrinol Metab; 1995 Dec; 80(12):3621-7. PubMed ID: 8530610 [Abstract] [Full Text] [Related]
3. Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP. J Clin Endocrinol Metab; 1993 Nov; 77(5):1275-80. PubMed ID: 8077321 [Abstract] [Full Text] [Related]
4. Dopamine D2 receptor gene expression in human adenohypophysial adenomas. Stefaneanu L, Kovacs K, Horvath E, Buchfelder M, Fahlbusch R, Lancranjan L. Endocrine; 2001 Apr; 14(3):329-36. PubMed ID: 11444429 [Abstract] [Full Text] [Related]
5. Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas. Tampanaru-Sarmesiu A, Stefaneanu L, Thapar K, Kovacs K, Donnelly T, Metz CN, Bucala R. Arch Pathol Lab Med; 1997 Apr; 121(4):404-10. PubMed ID: 9140312 [Abstract] [Full Text] [Related]
6. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. Asa SL, Bamberger AM, Cao B, Wong M, Parker KL, Ezzat S. J Clin Endocrinol Metab; 1996 Jun; 81(6):2165-70. PubMed ID: 8964846 [Abstract] [Full Text] [Related]
7. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. Lidhar K, Korbonits M, Jordan S, Khalimova Z, Kaltsas G, Lu X, Clayton RN, Jenkins PJ, Monson JP, Besser GM, Lowe DG, Grossman AB. J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037 [Abstract] [Full Text] [Related]
8. Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies. Barlier A, Zamora AJ, Grino M, Gunz G, Pellegrini-Bouiller I, Morange-Ramos I, Figarella-Branger D, Dufour H, Jaquet P, Enjalbert A. J Neuroendocrinol; 1999 Jul; 11(7):491-502. PubMed ID: 10444306 [Abstract] [Full Text] [Related]
9. Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries. Sanno N, Jin L, Qian X, Osamura RY, Scheithauer BW, Kovacs K, Lloyd RV. J Clin Endocrinol Metab; 1997 Jun; 82(6):1974-82. PubMed ID: 9177416 [Abstract] [Full Text] [Related]
10. Identification of corticotrophs in the human pituitary with mAB lu-5, a novel immunocytochemical marker. Kovacs K, Ryan N, Stefaneanu L. Pathol Res Pract; 1987 Dec; 182(6):775-9. PubMed ID: 2449679 [Abstract] [Full Text] [Related]
17. Analysis of pituitary hormones and chromogranin A mRNAs in null cell adenomas, oncocytomas, and gonadotroph adenomas by in situ hybridization. Lloyd RV, Jin L, Fields K, Chandler WF, Horvath E, Stefaneanu L, Kovacs K. Am J Pathol; 1991 Sep; 139(3):553-64. PubMed ID: 1653518 [Abstract] [Full Text] [Related]
19. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. Jin L, Qian X, Kulig E, Sanno N, Scheithauer BW, Kovacs K, Young WF, Lloyd RV. Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163 [Abstract] [Full Text] [Related]